Open, randomised, crossover study assessing the effects of Lisdexamfetamine dimesylate on cytochrome P450 substrate pharmacokinetics in Volunteers.

Trial Profile

Open, randomised, crossover study assessing the effects of Lisdexamfetamine dimesylate on cytochrome P450 substrate pharmacokinetics in Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Lisdexamfetamine (Primary) ; Caffeine; Dextromethorphan; Midazolam; Omeprazole
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 17 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top